IRIS Enters Supply Agreement With Broadlane

IRIS International, a manufacturer and marketer of automated IVD urinalysis systems and medical devices used in hospitals and reference clinical laboratories worldwide, has entered into a supply agreement for its iQ200 Automated Urine Microscopy Analyzer and related products with Broadlane, a provider of procurement management and other business services to the healthcare industry.

Under the terms of the three-year, dual-source agreement, effective March 1, Broadlane will offer to its customers the iQ200 Automated Urine Microscopy Analyzer and flagship iQ200 System, which combines the iQ200 analyzer with the AX-4280 Automated Urine Chemistry Analyzer. The combined system results in the only fully integrated platform in the world performing complete urinalysis, both chemistry and microscopy.

Broadlane is a privately held San Francisco-based company that manages supply spending of approximately $7 billion.